Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Pharmacology, Biochemistry, and Behavior
|
January 15, 2019
Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity
Susanne Nikolaus, Hans-Jörg Wittsack, Markus Beu, et al.
Annals of Nuclear Medicine
|
October 17, 2025
Quantitative evaluation of <sup>123</sup>I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisited
Lukas Kessler, Stephan Settelmeier, Kim M Pabst, et al.
Scientific Reports
|
June 14, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.
Scientific Reports
|
November 8, 2019
Differential effects of D-cycloserine and amantadine on motor behavior and D<sub>2/3</sub> receptor binding in the nigrostriatal and mesolimbic system of the adult rat
Susanne Nikolaus, Hans-Jörg Wittsack, Frithjof Wickrath, et al.
Diagnostics (Basel, Switzerland)
|
June 24, 2022
Diagnostic Performance of <sup>99m</sup>Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study
Simone Agnes Schenke, Alfredo Campennì, Murat Tuncel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Frontiers in Neurology
|
August 19, 2015
Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
Guido Widman, Kristin Golombeck, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <i>EGFR</i>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
Martin Schuler, Jörg Hense, Kaid Darwiche, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2019
Prospective comparison of whole-body MRI and <sup>68</sup>Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy
Lino M Sawicki, Julian Kirchner, Carolin Buddensieck, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Pharmacology, Biochemistry, and Behavior
|
January 15, 2019
Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity
Susanne Nikolaus, Hans-Jörg Wittsack, Markus Beu, et al.
Annals of Nuclear Medicine
|
October 17, 2025
Quantitative evaluation of <sup>123</sup>I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisited
Lukas Kessler, Stephan Settelmeier, Kim M Pabst, et al.
Scientific Reports
|
June 14, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.
Scientific Reports
|
November 8, 2019
Differential effects of D-cycloserine and amantadine on motor behavior and D<sub>2/3</sub> receptor binding in the nigrostriatal and mesolimbic system of the adult rat
Susanne Nikolaus, Hans-Jörg Wittsack, Frithjof Wickrath, et al.
Diagnostics (Basel, Switzerland)
|
June 24, 2022
Diagnostic Performance of <sup>99m</sup>Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study
Simone Agnes Schenke, Alfredo Campennì, Murat Tuncel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Frontiers in Neurology
|
August 19, 2015
Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
Guido Widman, Kristin Golombeck, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <i>EGFR</i>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
Martin Schuler, Jörg Hense, Kaid Darwiche, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2019
Prospective comparison of whole-body MRI and <sup>68</sup>Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy
Lino M Sawicki, Julian Kirchner, Carolin Buddensieck, et al.
Page
of 11